Navigation Links
Pharmasset Reports Positive Results from its HCV Clinical Programs
Date:1/6/2011

a preliminary proof-of-concept for an all oral, nucleotide combination regimen."Calendar Year 2011 Anticipated Milestones:-- Pharmasset expects to report SVR12 data from its ongoing phase 2b trial with PSI-7977 in HCV genotype 2/3 patients in the second quarter of 2011

-- Pharmasset expects to report the 12 week interim analysis from its PSI-7977 Phase 2b genotype 1 arms in the second quarter of 2011

-- Pharmasset expects to initiate a 24 week Phase 2b trial with PSI-7977 in the second quarter of 2011

-- Pharmasset expects to initiate a Phase 2 study with PSI-7977 and PSI-938 in mid-2011

-- Pharmasset plans to file an IND for PSI-661 in the first quarter of 2011 and to initiate a phase 1 trial in the second quarter of 2011

-- Roche expects to initiate INFORM-SVR with RG7128 and RG7227 in the first quarter of 2011

-- Roche expects to initiate a phase 2 study with RG7128 in HCV genotype 2/3 patients in the first half of 2011

-- Roche expects to initiate a phase 3 program with RG7128 in 2011

About PharmassetPharmasset is a clinical-stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset's primary focus is on the development of oral therapeutics for the treatment of hepatitis C virus (HCV). Our research and development efforts focus on nucleoside/tide analogs, a class of compounds which act as alternative substrates for the viral polymerase, thus inhibiting viral replication. We currently have four clinical-stage product candidates. RG7128, a cytosine nucleoside analog for chronic HCV infection, is in two Phase 2b clinical studies in combination with Pegasys® plus Copegus® and is also in the INFORM studies, the first series of studies designed to assess the potential of combinations of small molecules without Pegasys® and Copegus® to treat chronic HCV. These clinical studies are being conducted through a strate
'/>"/>

SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
10. Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C
11. Pharmasset Receives Notice of Allowance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015 When they began experiencing significant ... vendor their system would no longer be supported, ... a better structured solution to support their radiology ... to its interface capabilities and its 2014 EHR ... to the hospital,s radiology department. Avreo,s experienced team ...
(Date:3/26/2015)...  CCS Medical ("CCS"), one of the nation,s ... with chronic conditions, has named Rodney Carson ... March 23.  Mr. Carson joins CCS from MDLIVE, ... President of Operations. Prior to ... President of Operations at NationsHealth, (n/k/a Convey Health ...
(Date:3/26/2015)... , March 26, 2015 Zimmer Holdings, Inc. ... ® Advanced Bearing Technology with Vitamin E ... paper published earlier this month reported that, at 96 ... Advanced Bearing Technology featuring Vitamin E grafted highly ... significant wear rate reduction of 95 percent, with no ...
Breaking Medicine Technology:Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2CCS Medical Team Hires Industry Operator Rodney Carson as CEO 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 2Zimmer Announces New Testing Milestone For Vitamin E Advanced Bearing Technology 3
... 26, 2011 Rochester Medical Corporation (NASDAQ: ROCM ... Thursday, May 5, 2011.  The Company will then hold a ... will begin at 3:30 p.m. central time (4:30 p.m. eastern ... and can be accessed at Rochester Medical,s website at ...
... CARY, N.C., April 26, 2011 Cetero ... (CRO), today announced the appointment of James "Jay" Dixon ... spent more than 25 years in the pharmaceutical, biotechnology ... to support Cetero,s objective of maintaining its market leadership ...
Cached Medicine Technology:Rochester Medical Announces Second Quarter 2011 Earnings Conference Call Thursday, May 5, 2011 2Cetero Research Names 25-Year Industry Veteran James Dixon to Head Quality and Compliance 2
(Date:3/27/2015)... London, UK (PRWEB) March 27, 2015 ... that it has appointed Sean Fitzgerald, a former technology ... Chief Operating Officer and Interim Chief Financial Officer. , ... leading education technology innovator, EverFi, backed by Amazon founder ... Twitter founder Evan Williams. Prior to EverFi, he was ...
(Date:3/27/2015)... Bellevue, WA (PRWEB) March 27, 2015 ... it can be hard to know where to begin. ... an experienced Seattle trucking accident attorney, offers accident victims ... financial, and legal assistance to ensure their personal injury ... eBook begins by describing the first actions that should ...
(Date:3/27/2015)... 27, 2015 Approximately 300 advocates ... Kids Coalition Lobby Day to lobby for physical ... Program (SHIP). Everlast Climbing was especially interested ... SF343/HF498 which would strengthen physical education programs by ... and other measures to strengthen physical education in ...
(Date:3/27/2015)... 2015 Canadian Cannabis Clinics ( ... and utilization of medical cannabis as a treatment ... doctors and clinics dedicated to providing access to ... gateway for patients searching for medical marijuana treatment ... launched their sub domain for Canada. , ...
(Date:3/27/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... Peace is through the Laws of Peace written in the ... The article titled, “Yahweh’s Way-The Great Difference” focuses on the ... from the original biblical instructions has caused mass chaos worldwide. ... created in the world is based on man-made laws that ...
Breaking Medicine News(10 mins):Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Canadian Cannabis Clinics (CCC) to Join the Canada.MarijuanaDoctors.com Network 2Health News:The World Does Not Have to Continue in Misery, Says Yisrayl Hawkins in New Article 2
... Eden Medical Center a health affiliate with campuses in ... decision to call off its program to provide elective ... made available through the California Medical Assistance Commission. ... who will now be referred to various other hospitals ...
... AZD2171 which reduced the size and number of polyps in ... soon be used in humans with bowel cancer. , The ... Carcinogenesis, and Dr.Robert Goodlad, leader of the research team hopes that ... to treat polyps in humans thus preventing tumours. , Nearly ...
... smoking cessation therapy used to help reduce adverse events ... of death for smokers admitted to// the intensive care ... 2006, the 72nd annual international scientific assembly of the ... smokers admitted to the ICU who received nicotine replacement ...
... away with invasive breast reconstruction surgery, replaced by an ... suggest University of Pittsburgh researchers who are investigating the ... tissue. ,In animal models, the researchers hope ... that are seeded onto microscopic scaffold structures will enable ...
... alcohol beverages can play a role in a healthful ... //diseases, including coronary heart disease, diabetes, obesity, cognitive disorders ... presented papers at a recent conference on the role ... ,The conference, “Beer: To Your Health!” convened by ...
... research has unearthed substantial evidence to prove that smoking cigarettes ... to the health// of co passengers. If it is children ... researchers from Wellington School of Medicine. ,Traveling with ... can be compared with an evening spent in a smoky ...
Cached Medicine News:Health News:Smoking Cessation Therapy May be Harmful for ICU Patients 2Health News:Breast reconstruction may be possible with fat stem cells 2Health News:Daily Moderate Consumption of Beer May be Healthy 2
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
... The unmatched performance of CLS restores ... optimal hemodynamics even when the patient is ... concept of prevention, early detection and restoration ... button) programming and patient management via Home ...
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
Medicine Products: